Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy

Ads

You May Also Like

Rexahn Announces Adjournment of Annual Meeting of Shareholders until Wednesday, June 27, 2018

Three of four proposals pass with shareholder approval Annual Meeting adjourned solely with respect ...

Heat Biologics Reports Fiscal Year 2016 Financial Results

DURHAM, N.C., March 31, 2017 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a ...